Symbols / SNYR Stock $0.40 -0.08% Synergy CHC Corp.

Healthcare • Medical Distribution • United States • NCM
SNYR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Jack Ross
Exch · Country NCM · United States
Market Cap 4.52M
Enterprise Value 28.71M
Income -12.34M
Sales 30.38M
FCF (ttm) 2.04M
Book/sh -2.05
Cash/sh 0.23
Employees 28
Insider 10d —
IPO Oct 23, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 4.21
Forward P/E 0.79
PEG —
P/S —
P/B -0.20
P/C —
EV/EBITDA -3.45
EV/Sales 0.94
Quick Ratio 0.71
Current Ratio 1.22
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.27
EPS next Y 0.51
EPS Growth —
Revenue Growth -41.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-04-01
ROA -39.89%
ROE —
ROIC —
Gross Margin 66.83%
Oper. Margin -219.45%
Profit Margin -40.62%
Shs Outstand 11.30M
Shs Float 4.90M
Insider Own 56.19%
Instit Own 15.26%
Short Float 35.45%
Short Ratio 0.53
Short Interest 1.77M
52W High 4.00
vs 52W High -90.01%
52W Low 0.39
vs 52W Low 3.79%
Beta 1.47
Impl. Vol. —
Rel Volume 0.29
Avg Volume 1.34M
Volume 389.12K
Target (mean) $6.25
Tgt Median $6.25
Tgt Low $5.50
Tgt High $7.00
# Analysts 2
Recom Strong_buy
Prev Close $0.40
Price $0.40
Change -0.08%
About

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Westbrook, Maine.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.25
Mean price target
2. Current target
$0.40
Latest analyst target
3. DCF / Fair value
$3.25
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.40
Low
$5.50
High
$7.00
Mean
$6.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 main Ascendiant Capital Buy → Buy $6
2026-02-02 init Ascendiant Capital — → Buy $5
2025-11-14 main Roth Capital Buy → Buy $7
2025-01-21 init Roth MKM — → Buy $10
News
RSS: Latest SNYR news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
30.38
-12.78%
34.83
-18.57%
42.78
Operating Revenue
30.38
-12.78%
34.83
-18.57%
42.78
Cost Of Revenue
10.08
-9.95%
11.19
+4.62%
10.70
Reconciled Cost Of Revenue
10.08
-9.95%
11.19
+4.62%
10.70
Gross Profit
20.30
-14.13%
23.64
-26.30%
32.08
Operating Expense
22.10
+23.87%
17.84
-16.13%
21.27
Selling General And Administration
21.97
+24.05%
17.71
-16.63%
21.24
Selling And Marketing Expense
13.14
+1.13%
12.99
-14.47%
15.19
General And Administrative Expense
8.83
+87.19%
4.72
-22.05%
6.05
Other Gand A
8.83
+87.19%
4.72
-22.05%
6.05
Total Expenses
32.18
+10.84%
29.03
-9.19%
31.97
Operating Income
-1.80
-131.00%
5.80
-46.32%
10.81
Total Operating Income As Reported
-8.46
-245.81%
5.80
-46.32%
10.81
EBITDA
-6.17
-195.44%
6.47
-40.37%
10.84
Normalized EBITDA
0.49
-92.42%
6.47
-40.37%
10.84
Reconciled Depreciation
0.13
+0.00%
0.13
+300.01%
0.03
EBIT
-6.30
-199.55%
6.33
-41.42%
10.81
Total Unusual Items
-6.66
0.00
-100.00%
0.00
Total Unusual Items Excluding Goodwill
-6.66
0.00
-100.00%
0.00
Special Income Charges
-6.66
0.00
—
Write Off
6.66
0.00
—
Net Income
-12.34
-680.77%
2.12
-66.48%
6.34
Pretax Income
-12.22
-648.87%
2.23
-66.12%
6.57
Net Non Operating Interest Income Expense
-5.90
-43.89%
-4.10
+3.09%
-4.23
Interest Expense Non Operating
5.92
+44.20%
4.11
-3.09%
4.24
Net Interest Income
-5.90
-43.89%
-4.10
+3.09%
-4.23
Interest Expense
5.92
+44.20%
4.11
-3.09%
4.24
Interest Income Non Operating
0.02
+889.17%
0.00
-5.75%
0.00
Interest Income
0.02
+889.17%
0.00
-5.75%
0.00
Other Income Expense
-4.52
-953.84%
0.53
+34803.63%
0.00
Other Non Operating Income Expenses
2.14
+304.11%
0.53
+34803.63%
0.00
Gain On Sale Of Security
—
0.02
+1149.44%
0.00
Tax Provision
0.12
+15.07%
0.10
-56.56%
0.23
Tax Rate For Calcs
0.00
+425.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.40
0.00
0.00
Net Income Including Noncontrolling Interests
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income From Continuing Operation Net Minority Interest
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income From Continuing And Discontinued Operation
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income Continuous Operations
-12.34
-680.77%
2.12
-66.48%
6.34
Normalized Income
-7.08
-433.15%
2.12
-66.48%
6.34
Net Income Common Stockholders
-12.34
-680.77%
2.12
-66.48%
6.34
Diluted EPS
—
0.28
-67.44%
0.86
Basic EPS
—
0.28
-67.44%
0.86
Basic Average Shares
—
7.59
+2.91%
7.37
Diluted Average Shares
—
7.63
+3.48%
7.37
Diluted NI Availto Com Stockholders
-12.34
-680.77%
2.12
-66.48%
6.34
Depreciation Amortization Depletion Income Statement
0.13
+0.00%
0.13
+300.01%
0.03
Depreciation And Amortization In Income Statement
0.13
+0.00%
0.13
+300.01%
0.03
Line Item Trend 2025-12-31 2024-12-31
Total Assets
10.16
-37.81%
16.34
Current Assets
10.01
-37.64%
16.06
Cash Cash Equivalents And Short Term Investments
2.62
+281.19%
0.69
Cash And Cash Equivalents
2.62
+281.19%
0.69
Cash Financial
—
0.69
Receivables
3.20
-72.61%
11.70
Accounts Receivable
3.20
-39.80%
5.32
Gross Accounts Receivable
3.58
-32.70%
5.32
Allowance For Doubtful Accounts Receivable
-0.38
0.00
Other Receivables
—
2.00
Loans Receivable
0.00
-100.00%
4.38
Inventory
3.74
+117.73%
1.72
Raw Materials
0.41
+198.87%
0.14
Finished Goods
3.33
+110.64%
1.58
Prepaid Assets
0.35
-81.12%
1.86
Restricted Cash
0.10
+0.00%
0.10
Total Non Current Assets
0.15
-47.06%
0.28
Goodwill And Other Intangible Assets
0.15
-47.06%
0.28
Other Intangible Assets
0.15
-47.06%
0.28
Total Liabilities Net Minority Interest
33.29
+0.96%
32.97
Current Liabilities
8.24
-52.07%
17.18
Payables And Accrued Expenses
6.48
+19.16%
5.43
Payables
0.64
-36.56%
1.01
Current Accrued Expenses
5.83
+31.90%
4.42
Total Tax Payable
0.64
-36.56%
1.01
Income Tax Payable
0.09
-63.74%
0.24
Current Debt And Capital Lease Obligation
1.76
-85.00%
11.73
Current Debt
1.76
-85.00%
11.73
Other Current Borrowings
1.76
-85.00%
11.73
Current Deferred Liabilities
0.00
-93.71%
0.02
Current Deferred Revenue
0.00
-93.71%
0.02
Other Current Liabilities
0.00
—
Total Non Current Liabilities Net Minority Interest
25.06
+58.68%
15.79
Long Term Debt And Capital Lease Obligation
25.06
+58.68%
15.79
Long Term Debt
25.06
+58.68%
15.79
Stockholders Equity
-23.13
-39.06%
-16.63
Common Stock Equity
-23.13
-39.06%
-16.63
Capital Stock
0.00
+31.03%
0.00
Common Stock
0.00
+31.03%
0.00
Share Issued
11.48
+31.67%
8.72
Ordinary Shares Number
11.30
+32.34%
8.54
Treasury Shares Number
0.18
+0.00%
0.18
Additional Paid In Capital
33.59
+21.53%
27.64
Retained Earnings
-56.44
-27.98%
-44.10
Gains Losses Not Affecting Retained Earnings
-0.15
-222.92%
-0.05
Treasury Stock
0.13
+0.00%
0.13
Other Equity Adjustments
-0.15
-222.92%
-0.05
Total Equity Gross Minority Interest
-23.13
-39.06%
-16.63
Total Capitalization
1.93
+329.21%
-0.84
Working Capital
1.78
+258.13%
-1.12
Invested Capital
3.69
-66.13%
10.88
Total Debt
26.81
-2.55%
27.52
Net Debt
24.19
-9.82%
26.83
Net Tangible Assets
-23.28
-37.62%
-16.91
Tangible Book Value
-23.28
-37.62%
-16.91
Interest Payable
0.30
0.00
Other Inventories
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-2.59
+46.18%
-4.80
-1238.98%
0.42
Cash Flow From Continuing Operating Activities
-2.59
+46.18%
-4.80
-1238.98%
0.42
Net Income From Continuing Operations
-12.34
-680.77%
2.12
-66.48%
6.34
Depreciation Amortization Depletion
0.13
+0.00%
0.13
+300.01%
0.03
Amortization Cash Flow
0.13
+0.00%
0.13
+300.01%
0.03
Depreciation And Amortization
0.13
+0.00%
0.13
+300.01%
0.03
Amortization Of Intangibles
0.13
+0.00%
0.13
+300.01%
0.03
Other Non Cash Items
4.02
+4174.29%
-0.10
+97.80%
-4.47
Pension And Employee Benefit Expense
0.00
+100.00%
-0.25
0.00
Stock Based Compensation
0.98
0.00
—
Asset Impairment Charge
5.30
+4126.21%
0.13
-50.06%
0.25
Operating Gains Losses
-2.13
-883.31%
-0.22
-103.39%
-0.11
Net Foreign Currency Exchange Gain Loss
0.02
-42.42%
0.04
+133.14%
-0.11
Change In Working Capital
1.46
+121.21%
-6.87
-324.18%
-1.62
Change In Receivables
1.86
+140.27%
-4.62
-444.27%
1.34
Changes In Account Receivables
1.51
+147.12%
-3.21
-333.20%
1.38
Change In Inventory
-2.92
-254.71%
1.88
-52.78%
3.99
Change In Prepaid Assets
1.51
+208.13%
-1.40
-111.95%
-0.66
Change In Payables And Accrued Expense
1.03
+137.32%
-2.75
+56.34%
-6.30
Change In Payable
1.03
+137.32%
-2.75
+56.34%
-6.30
Change In Account Payable
1.11
+139.56%
-2.81
+56.71%
-6.49
Change In Other Working Capital
-0.02
-326.13%
0.01
+11.60%
0.01
Investing Cash Flow
0.00
0.00
0.00
Financing Cash Flow
4.65
-3.11%
4.80
+329.77%
-2.09
Cash Flow From Continuing Financing Activities
4.65
-3.11%
4.80
+329.77%
-2.09
Net Issuance Payments Of Debt
2.86
+172.93%
-3.92
-87.54%
-2.09
Issuance Of Debt
21.00
+1443.84%
1.36
+277.78%
0.36
Repayment Of Debt
-18.14
-243.44%
-5.28
-115.48%
-2.45
Long Term Debt Issuance
21.00
+1443.84%
1.36
+277.78%
0.36
Long Term Debt Payments
-18.14
-243.44%
-5.28
-115.48%
-2.45
Net Long Term Debt Issuance
2.86
+172.93%
-3.92
-87.54%
-2.09
Net Common Stock Issuance
3.72
-55.70%
8.40
0.00
Net Other Financing Charges
-1.92
-686.67%
0.33
—
Changes In Cash
2.07
+297262.36%
0.00
+100.04%
-1.67
Effect Of Exchange Rate Changes
-0.14
-347.30%
0.05
+143.80%
-0.12
Beginning Cash Position
0.79
+7.56%
0.73
-71.01%
2.53
End Cash Position
2.72
+245.51%
0.79
+7.56%
0.73
Free Cash Flow
-2.59
+46.18%
-4.80
-1238.98%
0.42
Interest Paid Supplemental Data
2.95
-24.38%
3.91
-6.44%
4.17
Income Tax Paid Supplemental Data
0.15
0.00
0.00
Change In Income Tax Payable
-0.08
-247.04%
0.06
-69.13%
0.19
Change In Tax Payable
-0.08
-247.04%
0.06
-69.13%
0.19
Common Stock Issuance
3.72
-55.70%
8.40
0.00
Issuance Of Capital Stock
3.72
-55.70%
8.40
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category